Key result
Coronary microarray profiling identifies 56 differentially expressed genes in atherosclerosis, highlighting 49 novel targets.
Case-Control (n=15)
Answers are grounded in this paper and cite their sources.
Genetic factors increase the risk to coronary artery disease (CAD). To date, a limited number of genes that potentially contribute to development of CAD have been identified. In this study, we have performed large-scale gene expression analysis of approximately 12,000 human genes in nine severely atherosclerotic and six nonatherosclerotic human coronary arteries using oligonucleotide microarrays. Fifty-six genes showed differential expression in atherosclerotic coronary artery tissues; expression of 55 genes was increased in atherosclerotic coronary arteries, whereas only one gene, GST, encoding a reducing agent, showed downregulated expression. The expression data of selected genes were validated by quantitative RT-PCR analysis as well as immunostaining. The associations of 49 genes with CAD appear to be novel, and they include genes encoding ICAM-2, PIM-2, ECGF1, fusin, B cell activator (BL34, GOS8), Rho GTPase activating protein-4, retinoic acid receptor responder, beta2-arrestin, membrane aminopeptidase, cathepsins K and H, MIR-7, TNF-alpha-induced protein 2 (B94), and flavocytochrome 558. In conclusion, we have identified 56 genes whose expression is associated with CAD, and 49 of them may represent new genes linked to CAD.
No takes yet. Share an insight, caveat, or question.
Archacki et al. (2003) conducted a case-control in Coronary artery disease (n=15). Severe coronary atherosclerosis vs. Nonatherosclerotic human coronary arteries was evaluated on Differential gene expression among approximately 12,000 human genes. Oligonucleotide microarray profiling of atherosclerotic vs nonatherosclerotic coronary arteries identified 56 differentially expressed genes (55 upregulated, 1 downregulated), 49 novel to CAD.
Synapse has enriched 10 related papers. Consider them for comparative context: